相关实验视频
Updated: May 25, 2025

09:09
In Silico Clinical Trials for Cardiovascular Disease
Published on: May 27, 2022
1.6K
系统地评估当前COVID-19挑战试验的风险.
1Institute for Health, School of Public Health, and Department of Philosophy, Rutgers University. 112 Paterson Street, Room 400, New Brunswick, NJ 08901, USA.
Vaccine
|February 27, 2025
概括
对SARS-CoV-2 (COVID) 的人类挑战试验对于符合条件的参与者来说是道德上可以接受的. 系统性风险评估显示,在这些关键的COVID-19研究中,个人面临的潜在风险最小.
科学领域:
- 传染性疾病 传染性疾病
- 临床试验 临床试验
- 生物伦理学生物伦理学
背景情况:
- 国际合作启动了SARS-CoV-2 (COVID) 人类挑战试验 (HCT).
- 之前关于COVID HCTs的建议因参与者风险过高而面临道德批评.
研究的目的:
- 系统地评估与计划中的COVID人类挑战试验相关的风险.
- 为解决有关COVID-19研究参与者安全的伦理问题.
主要方法:
- 进行了对COVID人类挑战试验固有的风险的系统分析.
- 评估不同人群的风险可接受性.
主要成果:
- 确定COVID HCTs中的风险对一些人群来说很高.
- 对于符合条件的个人来说,风险是可以接受的,可能是最小的.
结论:
- 计划中的COVID人类挑战试验对符合条件的参与者来说是道德上合理的.
- 强调需要在未来的高特区进行系统的风险评估,包括在流行病期间进行的风险评估.
相关概念视频
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
111
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
111
Clinical Trials
6.6K
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
There are four phases in a clinical trial. A phase one...
6.6K
Strategies for Assessing and Addressing Confounding
79
Confounding is a critical issue in epidemiological studies, often leading to misleading conclusions about associations between exposures and outcomes. It occurs when the relationship between the exposure and the outcome is mixed with the effects of other factors that influence the outcome. Given that, addressing confounding is of high importance for drawing accurate inferences in research.
Confounding can be addressed at both the design phase of a study and through analytical methods after data...
Confounding can be addressed at both the design phase of a study and through analytical methods after data...
79
Hazard Ratio
76
The hazard ratio (HR) is a widely used measure in clinical trials to compare the risk of events, such as death or disease recurrence, between two groups over time. It reflects the ratio of hazard rates—the instantaneous risk of the event occurring—between a treatment group and a control group. This measure provides valuable insights into the relative effectiveness of a treatment by assessing how the risk of an event differs between the two groups.
For example, in a clinical trial...
For example, in a clinical trial...
76
Controls in Experiments
6.9K
When conducting an experiment, it is crucial to have control to reduce bias and accurately measure the dependent variables. It also marks the results more reliable. Controls are elements in an experiment that have the same characteristics as the treatment groups but are not affected by the independent variable. By sorting these data into control and experimental conditions, the relationship between the dependent and independent variables can be drawn. A randomized experiment always includes a...
6.9K
Steps in Outbreak Investigation
102
In the ever-evolving field of public health, statistical analysis serves as a cornerstone for understanding and managing disease outbreaks. By leveraging various statistical tools, health professionals can predict potential outbreaks, analyze ongoing situations, and devise effective responses to mitigate impact. For that to happen, there are a few possible stages of the analysis:
102

